請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/5158
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 郭明良(Min-Liang Kuo) | |
dc.contributor.author | Kai-Hang Lei | en |
dc.contributor.author | 李啟恆 | zh_TW |
dc.date.accessioned | 2021-05-15T17:52:44Z | - |
dc.date.available | 2020-08-31 | |
dc.date.available | 2021-05-15T17:52:44Z | - |
dc.date.copyright | 2014-08-11 | |
dc.date.issued | 2014 | |
dc.date.submitted | 2014-08-08 | |
dc.identifier.citation | 1. Coussens LM & Werb Z (2002) Inflammation and cancer. Nature 420(6917):860-867.
2. Maiuri MC, et al. (2004) Nuclear factor-κB regulates inflammatory cell apoptosis and phagocytosis in rat carrageenin-sponge implant model. The American journal of pathology 165(1):115-126. 3. Huynh M-LN, Fadok VA, & Henson PM (2002) Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation. Journal of Clinical Investigation 109(1):41-50. 4. Balkwill F & Mantovani A (2001) Inflammation and cancer: back to Virchow? The lancet 357(9255):539-545. 5. Philip M, Rowley DA, & Schreiber H (2004) Inflammation as a tumor promoter in cancer induction. Seminars in Cancer Biology 14(6):433-439. 6. Leek RD, et al. (2000) Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. The Journal of pathology 190(4):430-436. 7. Grimshaw MJ, Wilson JL, & Balkwill FR (2002) Endothelin‐2 is a macrophage chemoattractant: implications for macrophage distribution in tumors. European journal of immunology 32(9):2393-2400. 8. Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nature Reviews Cancer 4(1):71-78. 9. Lu H, Ouyang W, & Huang C (2006) Inflammation, a key event in cancer development. Molecular cancer research : MCR 4(4):221-233. 10. Liu F, Xia Y, Parker AS, & Verma IM (2012) IKK biology. Immunological Reviews 246(1):239-253. 11. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, & Karin M (1997) A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388(6642):548-554. 12. Disis ML (2010) Immune regulation of cancer. Journal of Clinical Oncology 28(29):4531-4538. 13. Oeckinghaus A, Hayden MS, & Ghosh S (2011) Crosstalk in NF-[kappa] B signaling pathways. Nature immunology 12(8):695-708. 14. Mercurio F, et al. (1997) IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278(5339):860-866. 15. Cummins EP, et al. (2006) Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NFκB activity. Proceedings of the National Academy of Sciences 103(48):18154-18159. 16. Yamamoto Y, Verma UN, Prajapati S, Kwak Y-T, & Gaynor RB (2003) Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression. Nature 423(6940):655-659. 17. Lawrence T, Bebien M, Liu GY, Nizet V, & Karin M (2005) IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation. Nature 434(7037):1138-1143. 18. Albanese C, et al. (2003) IKKα regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. Molecular biology of the cell 14(2):585-599. 19. Carayol N & Wang C-Y (2006) IKKα stabilizes cytosolic β-catenin by inhibiting both canonical and non-canonical degradation pathways. Cellular signalling 18(11):1941-1946. 20. Lee D-F, et al. (2007) IKKβ suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 130(3):440-455. 21. Lee S, et al. (2004) IκB kinase β phosphorylates Dok1 serines in response to TNF, IL-1, or γ radiation. Proceedings of the National Academy of Sciences of the United States of America 101(50):17416-17421. 22. Chapuis N, et al. (2010) IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia. Blood 116(20):4240-4250. 23. Geutjes E, Bajpe P, & Bernards R (2012) Targeting the epigenome for treatment of cancer. Oncogene 31(34):3827-3844. 24. Dawson MA & Kouzarides T (2012) Cancer epigenetics: from mechanism to therapy. Cell 150(1):12-27. 25. Barski A, et al. (2007) High-resolution profiling of histone methylations in the human genome. Cell 129(4):823-837. 26. Krivtsov AV & Armstrong SA (2007) MLL translocations, histone modifications and leukaemia stem-cell development. Nature Reviews Cancer 7(11):823-833. 27. Kondo Y, et al. (2008) Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells. PLoS One 3(4):e2037. 28. Lee S, Kim J, Kim W, & Lee Y (2009) Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Oncogene 28(2):184-194. 29. Chen M-W, et al. (2010) H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer research 70(20):7830-7840. 30. Dong C, et al. (2012) G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. The Journal of clinical investigation 122(4):1469. 31. Tachibana M, Sugimoto K, Fukushima T, & Shinkai Y (2001) Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. Journal of Biological Chemistry 276(27):25309-25317. 32. Milner CM & Campbell RD (1993) The G9a gene in the human major histocompatibility complex encodes a novel protein containing ankyrin-like repeats. Biochem. J 290:811-818. 33. Brown SE, Campbell RD, & Sanderson CM (2001) Novel NG36/G9a gene products encoded within the human and mouse MHC class III regions. Mammalian Genome 12(12):916-924. 34. Tachibana M, et al. (2005) Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes & development 19(7):815-826. 35. Shankar SR, et al. (2013) G9a, a multipotent regulator of gene expression. Epigenetics : official journal of the DNA Methylation Society 8(1):16-22. 36. Ding J, et al. (2013) The Histone H3 Methyltransferase G9A Epigenetically Activates the Serine-Glycine Synthesis Pathway to Sustain Cancer Cell Survival and Proliferation. Cell metabolism 18(6):896-907. 37. Cha T-L, et al. (2005) Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. science 310(5746):306-310. 38. Kim E, et al. (2013) Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer cell 23(6):839-852. 39. Kuo H-P, et al. (2009) Phosphorylation of ARD1 by IKKβ contributes to its destabilization and degradation. Biochemical and biophysical research communications 389(1):156-161. 40. Huang J, et al. (2010) G9a and Glp methylate lysine 373 in the tumor suppressor p53. Journal of Biological Chemistry 285(13):9636-9641. 41. Zhong X, et al. (2014) Overexpressions of G9a and MCM7 in Esophageal Squamous Cell Carcinoma Associated with Poor Prognosis. Histopathology. 42. Dong C, et al. (2013) Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer cell 23(3):316-331. 43. Tezil T, Bodur C, Kutuk O, & Basaga H (2012) IKK-β mediates chemoresistance by sequestering FOXO3; a critical factor for cell survival and death. Cellular signalling 24(6):1361-1368. 44. Chen H, Yan Y, Davidson TL, Shinkai Y, & Costa M (2006) Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells. Cancer research 66(18):9009-9016. 45. Takahashi A, et al. (2012) DNA Damage Signaling Triggers Degradation of Histone Methyltransferases through APC/C(Cdh1) in Senescent Cells. Molecular cell 45(1):123-131. 46. Huang B, et al. (2011) RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor α. Oncogene 31(4):527-534. 47. Lee S, Kim J, Kim W, & Lee Y (2008) Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Oncogene 28(2):184-194. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/5158 | - |
dc.description.abstract | G9a 是哺乳動物的組蛋白甲基轉移酶,在不同癌症中常常會高度表現,使得抑癌基因靜默而無法轉錄,調控腫瘤發展的進程。由於轉譯後修飾對於調控蛋白的功能十分重要,而目前沒有文獻探討G9a的轉譯後修飾,因此我們利用生物資訊的軟體預測G9a可能的磷酸化位置,在其中發現可能具有IKKa/b的磷酸化位置。
在本篇的研究中,我們在293T細胞和乳癌細胞MCF-7、BT549中利用免疫沉澱方法以及GST pull down assay 證明了G9a可以在in vivo及 in vitro的情況下跟IKKa/b結合,在in vitro kinase assay的實驗中證明了IKKa/b確實可以磷酸化G9a。為了進一步探討IKKa/b對於G9a的調控,我們在293T cell過度表現IKKa/b後,發現G9a的蛋白質表現量會有明顯上升而RNA的量沒有太大改變,推斷IKKa/b可能影響到G9a轉譯或者是蛋白質的穩定度。因此在293T細胞中加入cycloheximide,可以發現過度表現IKKa/b的細胞可以減緩G9a的降解速度,而在MCF-7 細胞中把IKKa/b剔除則會使G9a的表現量下降,另外當加入細胞激素IL-1b後也可以看到G9a的蛋白質表現量有一定的上升,代表IKKa/b的活性調控G9a的穩定度。在乳癌細胞MCF-7中剔除IKKa/b也會造成細胞的生長、轉移和侵襲的能力下降,而由G9a所抑制的基因則是有所上升。由於G9a在癌症發生過程中扮演重要的調控角色,本篇研究發現IKKa/b可以藉由磷酸化G9a來調控它的功能來促進癌症發生,未來或許在G9a表現比較高的病人中,可以同時針對IKK跟G9a進行抑制,提高治療效果。 | zh_TW |
dc.description.abstract | G9a, also known as EHMT2, is a histone H3 lysine 9 methyltransferase, has been observed overexpression in various human cancers and contributes to the epigenetic silencing of tumor suppressor genes to promote cancer progression. Post-translational modification (PTM) is very important to regulate protein function. It has been shown that several epigenetic regulators were regulated by different PTMs. The post translational modification that regulates function of G9a had not been reported yet, therefore it is necessary to investigate the PTM of G9a. Interestingly, from the bioinformatics prediction, we found that G9a contains IKKa/b consensus phosphorylation site, suggesting a possible interaction between IKKa/b and G9a.
In this study, we used the co-immunoprecipitation in 293T cells, MCF-7 and BT549 breast cancer cells and GST pull down assay to prove that G9a interacted with IKKa and b in vivo and in vitro. By using in vitro kinase assay, we proved that G9a can be phosphorylated by both IKKa and b. To investigate the regulation of G9a by IKKa/b, we overexpressed IKKa/b in 293T cells and found the protein expression level of G9a was increased but not the RNA level. It suggested that IKKa/b may regulate the translation activity or protein stability of G9a. For this reason, we added cycloheximide in 293T cells to examine the half-life of G9a. The cells with overexpression of IKKa/b can prolong the half-life of G9a, on the contrary, knockdown of IKKa/b decreased G9a protein level in MCF-7 cells. Furthermore, the cytokine IL-1b can also enhance the protein level of G9a in MCF-7 cells, suggesting that the kinase activity of IKKa/b regulated protein stability of G9a. Knockdown of IKKa/b in MCF-7 cells inhibited cell growth, decreased migration and invasion ability, and increased the RNA level of the genes that suppressed by G9a. G9a had played an important role in cancer progression, this study reveals that IKKa/b can phosphorylate G9a to promote cancer progression. Targeting IKK and G9a in the cancer patients with G9a overexpression may potentially enhance the therapeutic efficacy in the future. | en |
dc.description.provenance | Made available in DSpace on 2021-05-15T17:52:44Z (GMT). No. of bitstreams: 1 ntu-103-R01b46019-1.pdf: 2802731 bytes, checksum: 3fa2712ada0cee0aae421349dbb681ce (MD5) Previous issue date: 2014 | en |
dc.description.tableofcontents | 口試委員會審定書 i
誌謝 ii 中文摘要 iii Abstract iv Chapter 1. Introduction 1 1.1 Inflammation and Cancer Progression 2 1.2 NF-κB Pathway and The Function of IKK 4 1.3 Histone Methyltransferase in Epigenetic and Cancer Progression 7 1.4 G9a Function in Cancer Progression 8 Chapter 2. Materials and Methods 11 Chapter 3. Results 20 3.1 IKKa/b Directly Interacts and Phosphorylates G9a 21 3.2 IKKa/b Increases the Protein Stability of G9a 22 3.3 IKKa/b Kinase Activity Enhances the Protein Stability of G9a 23 3.4 Knockdown of IKKa/b impairs G9a in Cancer Biological Functions 23 Chapter 4. Disscusion 25 Chapter 5. Figures and Legends 29 Chapter 6. References 45 | |
dc.language.iso | en | |
dc.title | IKK調控組蛋白甲基轉移酶G9a促進癌症發展之探討 | zh_TW |
dc.title | IKK Regulates Histone Methyltransferase G9a to Promote Cancer Progression | en |
dc.type | Thesis | |
dc.date.schoolyear | 102-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 張震東(Geen-Dong Chang),蕭宏昇(Michael Hsiao),洪文俊(Wen-Chun Hung) | |
dc.subject.keyword | IKK,組蛋白甲基轉移? G9a, | zh_TW |
dc.subject.keyword | IKK,histone methyltransferase G9a, | en |
dc.relation.page | 50 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2014-08-08 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 生化科學研究所 | zh_TW |
顯示於系所單位: | 生化科學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-103-1.pdf | 2.74 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。